Matches in Nanopublications for { ?s ?p "[Adjunctive therapy with recombinant human IGF-I (rhIGF-I)/recombinant human IGF binding protein-3 (rhIGFBP-3) has been shown to improve insulin sensitivity in both type 1 and type 2 diabetes and may have a role in the treatment of SIR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_assertion description "[Adjunctive therapy with recombinant human IGF-I (rhIGF-I)/recombinant human IGF binding protein-3 (rhIGFBP-3) has been shown to improve insulin sensitivity in both type 1 and type 2 diabetes and may have a role in the treatment of SIR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.
- NP800309.RAVd0QCOCi0U71S16XdFyEFV3287veK8ZBfu7IPghnSjQ130_assertion description "[Adjunctive therapy with recombinant human IGF-I (rhIGF-I)/recombinant human IGF binding protein-3 (rhIGFBP-3) has been shown to improve insulin sensitivity in both type 1 and type 2 diabetes and may have a role in the treatment of SIR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800309.RAVd0QCOCi0U71S16XdFyEFV3287veK8ZBfu7IPghnSjQ130_provenance.